Viewing Study NCT02183168


Ignite Creation Date: 2025-12-24 @ 6:28 PM
Ignite Modification Date: 2025-12-29 @ 4:23 PM
Study NCT ID: NCT02183168
Status: COMPLETED
Last Update Posted: 2023-11-24
First Post: 2014-07-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module